{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:43:00Z","timestamp":1793281380147,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["2023R1A2C1003601"],"award-info":[{"award-number":["2023R1A2C1003601"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Genom"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s13258-026-01801-8","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T04:17:17Z","timestamp":1789445837000},"page":"1369-1382","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transcriptomic and network analyses identify epigenetic regulators of drug-tolerant persister (DTP) subsets in EGFR-mutant HCC827 non-small cell lung cancer"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2209-0217","authenticated-orcid":false,"given":"JuneKyu","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3091-0649","authenticated-orcid":false,"given":"Euitaek","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1075-0011","authenticated-orcid":false,"given":"Soon Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"1801_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41698-022-00337-w","volume":"6","author":"SW Criscione","year":"2022","unstructured":"Criscione SW, Martin MJ, Oien DB, Gorthi A, Miragaia RJ, Zhang J, Chen H, Karl DL, Mendler K, Markovets A et al (2022) The landscape of therapeutic vulnerabilities in EGFR inhibitor osimertinib drug tolerant persister cells. npj Precis Oncol 6:95","journal-title":"npj Precis Oncol"},{"key":"1801_CR2","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1158\/2159-8290.CD-23-0225","volume":"13","author":"A Davies","year":"2023","unstructured":"Davies A, Zoubeidi A, Beltran H, Selth LA (2023) The transcriptional and epigenetic landscape of cancer cell lineage plasticity. Cancer Discov 13:1771\u20131788","journal-title":"Cancer Discov"},{"key":"1801_CR3","doi-asserted-by":"publisher","first-page":"6540","DOI":"10.21037\/tcr-24-690","volume":"13","author":"WCM Dempke","year":"2024","unstructured":"Dempke WCM, Fenchel K (2024) Targeting C797S mutations and beyond in non-small cell lung cancer\u2014a mini-review. Transl Cancer Res 13:6540\u20136549","journal-title":"Transl Cancer Res"},{"key":"1801_CR5","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41418-022-01088-8","volume":"30","author":"E Jung","year":"2023","unstructured":"Jung E, Ou S, Ahn SS, Yeo H, Lee YH, Shin SY (2023) The JNK-EGR1 signaling axis promotes TNF-alpha-induced endothelial differentiation of human mesenchymal stem cells via VEGFR2 expression. Cell Death Differ 30:356\u2013368","journal-title":"Cell Death Differ"},{"key":"1801_CR4","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s13258-025-01629-8","volume":"47","author":"C Jung","year":"2025","unstructured":"Jung C, Park J, Seo SB (2025) E3 ligase MIB1 regulates STAT1\/P21 signaling via regulation of FGFR1 in colorectal cancer. Genes Genomics 47:663\u2013670","journal-title":"Genes Genomics"},{"key":"1801_CR6","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.1158\/0008-5472.CAN-20-2811","volume":"81","author":"Y Kashima","year":"2021","unstructured":"Kashima Y, Shibahara D, Suzuki A, Muto K, Kobayashi IS, Plotnick D, Udagawa H, Izumi H, Shibata Y, Tanaka K et al (2021) Single-cell analyses reveal diverse mechanisms of resistance to EGFR tyrosine kinase inhibitors in lung cancer. Cancer Res 81:4835\u20134848","journal-title":"Cancer Res"},{"key":"1801_CR7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s13258-024-01604-9","volume":"47","author":"S Keum","year":"2025","unstructured":"Keum S, Lee YJ, Kim J-W, Rhee S (2025) Dual-specificity phosphatase 23 functions as a promising prognostic biomarker in non-small cell lung cancer. Genes Genomics 47:321\u2013329","journal-title":"Genes Genomics"},{"key":"1801_CR8","doi-asserted-by":"publisher","first-page":"2309824","DOI":"10.1080\/15592294.2024.2309824","volume":"19","author":"J Krushkal","year":"2024","unstructured":"Krushkal J, Zhao Y, Roney K, Zhu W, Brooks A, Wilsker D, Parchment RE, McShane LM, Doroshow JH (2024) Association of changes in expression of HDAC and SIRT genes after drug treatment with cancer cell line sensitivity to kinase inhibitors. Epigenetics 19:2309824","journal-title":"Epigenetics"},{"key":"1801_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41388-024-03220-z","volume":"44","author":"H Li","year":"2025","unstructured":"Li H, Li Y, Zheng X, Chen F, Zhang S, Xu S, Mu Y, Shen W, Tong J, Chen H et al (2025) RBM15 facilitates osimertinib resistance of lung adenocarcinoma through m6A-dependent epigenetic silencing of SPOCK1. Oncogene 44:307\u2013321","journal-title":"Oncogene"},{"key":"1801_CR10","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3892\/ol.2026.15497","volume":"31","author":"R Lin","year":"2026","unstructured":"Lin R, Zhang Y, Li H, Liang F (2026) Histone deacetylases: function in tumor development and therapeutic prospects (review). Oncol Lett 31:144","journal-title":"Oncol Lett"},{"key":"1801_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13045-020-00858-6","volume":"13","author":"Q Luo","year":"2020","unstructured":"Luo Q, Wang J, Zhao W, Peng Z, Liu X, Li B, Zhang H, Shan B, Zhang C, Duan C (2020) Vasculogenic mimicry in carcinogenesis and clinical applications. J Hematol Oncol 13:19","journal-title":"J Hematol Oncol"},{"key":"1801_CR12","first-page":"46","volume":"7","author":"M Minisini","year":"2024","unstructured":"Minisini M, Mascaro M, Brancolini C (2024) HDAC-driven mechanisms in anticancer resistance: epigenetics and beyond. Cancer Drug Resist 7:46","journal-title":"Cancer Drug Resist"},{"key":"1801_CR13","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41571-023-00815-5","volume":"20","author":"Y Pu","year":"2023","unstructured":"Pu Y, Li L, Peng H, Liu L, Heymann D, Robert C, Vallette F, Shen S (2023) Drug-tolerant persister cells in cancer: the cutting edges and future directions. Nat Rev Clin Oncol 20:799\u2013813","journal-title":"Nat Rev Clin Oncol"},{"key":"1801_CR14","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1158\/0008-5472.CAN-24-0274","volume":"84","author":"PH Rumde","year":"2024","unstructured":"Rumde PH, Burns TF (2024) A path to persistence after EGFR inhibition. Cancer Res 84:1188\u20131190","journal-title":"Cancer Res"},{"key":"1801_CR15","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s41568-024-00737-z","volume":"24","author":"M Russo","year":"2024","unstructured":"Russo M, Chen M, Mariella E, Peng H, Rehman SK, Sancho E, Sogari A, Toh TS, Balaban NQ, Batlle E et al (2024) Cancer drug-tolerant persister cells: from biological questions to clinical opportunities. Nat Rev Cancer 24:694\u2013717","journal-title":"Nat Rev Cancer"},{"key":"1801_CR16","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671\u2013675","journal-title":"Nat Methods"},{"key":"1801_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","volume":"141","author":"SV Sharma","year":"2010","unstructured":"Sharma SV, Lee DY, Li B, Quinlan MP, Takahashi F, Maheswaran S, McDermott U, Azizian N, Zou L, Fischbach MA et al (2010) A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141:69\u201380","journal-title":"Cell"},{"key":"1801_CR18","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s13258-025-01631-0","volume":"47","author":"H Shi","year":"2025","unstructured":"Shi H, Jiang Y, Mu H, Liu G, Cheng X, Kong W, Zhou X, Wen X, Wang X, Lin Y (2025a) PRDM14 promoted NSCLC cell proliferation, migration and invasion via modulating H3K27me3-mediated PEBP1\/Raf-1\/MEK\/ERK MAPK signaling. Genes Genomics 47:1027\u20131038","journal-title":"Genes Genomics"},{"key":"1801_CR19","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1038\/s41388-025-03461-6","volume":"44","author":"R Shi","year":"2025","unstructured":"Shi R, Farnsworth DA, Febres-Aldana CA, Chow JLM, Sheena R, Atwal T, Gomez Marti JL, Li S, Thomas KN, Lee C-M et al (2025b) Drug tolerance and persistence to EGFR inhibitor treatment are mediated by an ILK-SFK-YAP signaling axis in lung adenocarcinoma. Oncogene 44:2831\u20132849","journal-title":"Oncogene"},{"key":"1801_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1056\/NEJMoa1713137","volume":"378","author":"J-C Soria","year":"2018","unstructured":"Soria J-C, Ohe Y, Vansteenkiste J, Reungwetwattana T, Chewaskulyong B, Lee KH, Dechaphunkul A, Imamura F, Nogami N, Kurata T (2018) Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer. N Engl J Med 378:113\u2013125","journal-title":"N Engl J Med"},{"key":"1801_CR21","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1111\/cas.15674","volume":"114","author":"H Takahashi","year":"2023","unstructured":"Takahashi H, Sakakibara-Konishi J, Furuta M, Shoji T, Tsuji K, Morinaga D, Kikuchi E, Kikuchi J, Noguchi T, Hatanaka KC et al (2023) Notch pathway regulates osimertinib drug-tolerant persistence in EGFR-mutated non-small-cell lung cancer. Cancer Sci 114:1635\u20131650","journal-title":"Cancer Sci"},{"key":"1801_CR22","doi-asserted-by":"publisher","first-page":"112387","DOI":"10.1016\/j.isci.2025.112387","volume":"28","author":"Y Tian","year":"2025","unstructured":"Tian Y, Bhattacharya R, Yoo S, Jiang F, Park E, Lara Granados G, Shen Y, Park KS, Kaniskan HU, Jin J et al (2025) Epigenomic analysis identifies DTP subpopulation using HOPX to develop targeted therapy resistance in lung adenocarcinoma. iScience 28:112387","journal-title":"iScience"},{"key":"1801_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41388-020-01510-w","volume":"40","author":"HL Tumbrink","year":"2021","unstructured":"Tumbrink HL, Heimsoeth A, Sos ML (2021) The next tier of EGFR resistance mutations in lung cancer. Oncogene 40:1\u201311","journal-title":"Oncogene"},{"key":"1801_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/bs.acr.2020.06.001","volume":"148","author":"SL Wechman","year":"2020","unstructured":"Wechman SL, Emdad L, Sarkar D, Das SK, Fisher PB (2020) Vascular mimicry: triggers, molecular interactions and in vivo models. Adv Cancer Res 148:27\u201367","journal-title":"Adv Cancer Res"},{"key":"1801_CR25","doi-asserted-by":"publisher","first-page":"13322","DOI":"10.1038\/ncomms13322","volume":"7","author":"SC Williamson","year":"2016","unstructured":"Williamson SC, Metcalf RL, Trapani F, Mohan S, Antonello J, Abbott B, Leong HS, Chester CP, Simms N, Polanski R et al (2016) Vasculogenic mimicry in small cell lung cancer. Nat Commun 7:13322","journal-title":"Nat Commun"},{"key":"1801_CR26","doi-asserted-by":"publisher","first-page":"5761","DOI":"10.1007\/s00210-025-04665-z","volume":"399","author":"M Yusuf","year":"2026","unstructured":"Yusuf M (2026) CRISPR screens reveal YAP\/TEAD axis as a mediator of drug-tolerant cells in EGFR-mutant NSCLC. Naunyn Schmiedebergs Arch Pharmacol 399:5761\u20135776","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1801_CR27","doi-asserted-by":"publisher","first-page":"e06950","DOI":"10.1002\/advs.202506950","volume":"12","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Zhang X, Yang X, Chen X, Wang Y, Hu J, Liu R, Luo X (2025) EGFR-TKIs induced DPP4 drives metabolic reprogramming of persister cells in lung cancer. Adv Sci 12:e06950","journal-title":"Adv Sci"}],"container-title":["Genes & Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-026-01801-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13258-026-01801-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13258-026-01801-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:16:09Z","timestamp":1793279769000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13258-026-01801-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1801"],"URL":"https:\/\/doi.org\/10.1007\/s13258-026-01801-8","relation":{},"ISSN":["1976-9571","2092-9293"],"issn-type":[{"value":"1976-9571","type":"print"},{"value":"2092-9293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"19 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}